The FDA has approved a drug developed by Cytokinetics for its intended use as a treatment.
3 reports, 2 independent
Updated Jun 29
Gone quiet
- Reports
- 3
- Developments
- 3
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA has approved a drug developed by Cytokinetics for its intended use as a treatment.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Product Myqorzo received FDA approval.Sub-event
Cytokinetics drug moves toward global commercial rollout following regulatory approvals.1 source
FDA approves Cytokinetics' drug as a treatment.1 source
Keep exploring
The entities involved
- FDA
-
Cytokinetics
company in South San Francisco, United States
Related events
- The FDA is reviewing a drug approval application for a condition involving the company GAD.
- Experimental therapies require approval from the FDA.
- Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.
- The FDA recommended advancement for a new drug application submitted by a company.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.